Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
type
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

1385186

	registered interest
	date	06/12/2021
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Coronavirus: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of calls by the President of the United States and NGOs to waive intellectual property rights on COVID-19 vaccines.
	tabling member printed	Lord Hylton
	type	WrittenParliamentaryQuestion
	uin	HL4715
	answer	answer is ministerial correction date of answer 20/12/2021 answer text <p>Intellectual Property rights have been critical in underpinning innovators’ confidence to form over 300 partnerships - an unprecedented number - which have made real, positive impacts on vaccine delivery; examples include AstraZeneca and the Serum Institute of India, and Pfizer-BioNTech and BIOVAC in South Africa. These examples show what is possible when the right partners work together and share technology.</p><p> </p><p>While we must continue to ensure vaccine production needs are met globally, the WHO news release of 7 October made it clear that, “With global vaccine production now at nearly 1.5 billion doses per month, there is sufficient vaccine from a supply perspective to achieve global vaccination targets”. We must therefore also focus on issues of distribution and delivery to successfully vaccinate the globe.</p> answering member printed Lord Callanan question first answered 20/12/2021 13:11:13 answering member 4336 label Biography information for Lord Callanan
	tabling member	2018 label Biography information for Lord Hylton

1385185

	registered interest
	date	06/12/2021
	answering body	Foreign, Commonwealth and Development Office
	answering dept id	208
	answering dept short name	Foreign, Commonwealth and Development Office
	answering dept sort name	Foreign, Commonwealth and Development Office
	hansard heading	Gaza: Coronavirus
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what steps they are taking to ensure that residents in Gaza receive their fair share of COVID-19 vaccinations.
	tabling member printed	Lord Hylton
	type	WrittenParliamentaryQuestion
	uin	HL4714
	answer	answer is ministerial correction date of answer 20/12/2021 answer text <p>Tackling COVID-19 remains a priority for the Government. We welcome the steps that the parties have taken so far to coordinate responses to the COVID-19 pandemic, including ensuring that essential medical supplies and staff can access Gaza, and encourage further dialogue in this regard. The UK is committed to global equitable access to effective vaccines as demonstrated by our £548 million contribution to the COVAX Advance Market Commitment - the international initiative to support global equitable access to vaccines. The Occupied Palestinian Territories was one of the first to receive vaccines from this scheme. The UK has raised the need for equitable access to vaccines in discussions with both the Palestinian Authority and Government of Israel.</p> answering member printed Lord Ahmad of Wimbledon question first answered 20/12/2021 12:41:43 answering member 4210 label Biography information for Lord Ahmad of Wimbledon
	tabling member	2018 label Biography information for Lord Hylton